We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image
  • Published In : May 2023
  • Code : CMI5723
  • Pages :169
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

The global medical implants market was valued at US$ 102.52 Bn in 2022 and is forecast to reach a value of US$ 178.79 Bn by 2030 at a CAGR of 7.2% between 2023 and 2030. The global medical implants market is experiencing strong growth due to the increase in prevalence of chronic disease and growing geriatric (aging) population around the world. Moreover, increase in burden of musculoskeletal disorders and rise in adoption or demand for medical implants is expected to boost the market growth. However, factors such as high cost of treatment and stringent rules and regulations or stringent approval process are expected to hamper the market growth.

Global Medical Implants Market: Regional Insights

Based on geography, the global medical implants market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market during the forecast period owing to the increasing prevalence of chronic disease, growing geriatric population, rise in adoption of medical implants, and technological advancements in the field of medical implants in the region. For instance, with the rise in burden of chronic diseases and rising geriatric population, the demand for medical implants is also increasing. According to the Centers for Disease Control and Prevention (CDC), chronic diseases are the leading causes of death and disability in the United States. Moreover, around 85% of Americans over 65 years of age have at least one chronic health condition and 60% have at least two chronic conditions

Europe and Asia Pacific are also expected to witness robust growth in the global medical implants market owing to the rise in burden of chronic disease, growing geriatric population, rise in demand for safe/effective medical implants, government initiative/support, and well-established healthcare infrastructure in these regions. For instance, in February 2019, the Indian Government decided to regulate the sale, manufacture, and import of medical implants to ensure safe and tested medical devices reach the end user. Devices implanted into the body, or used for life support or sustenance, may pose potential risk and thus, must be strictly controlled.

Figure 1. Global Medical Implants Market Share (%), by Region, 2023

MEDICAL IMPLANTS MARKET

To learn more about this report, request a free sample copy

Global Medical Implants Market Drivers:

Rise in burden of chronic diseases to drive market growth

One of the key factors expected to augment the growth of the global medical implants market over the forecast period is the increase in prevalence of chronic disease, such as cardiovascular diseases (CVDs). Cardiac implantable electronic devices are designed to help control or monitor irregular heartbeats in people with certain heart rhythm disorders and heart failure. In February 2022, Abbott announced the world's first patient implants of a dual-chamber leadless pacemaker system as part of the AVEIR DR i2i pivotal clinical study. Abbott's investigational Aveir dual-chamber leadless pacemaker represents a significant technological milestone for leadless pacing technology and is the first to occur around the world within the pivotal trial.

Growing geriatric population to propel market growth

Another factor which is driving the growth of the global medical implants market is the growing geriatric (aging) population around the world. For instance, increasing number of older individuals is accompanied by increasing health concerns, presenting unique demand for the medical devices. Cardiovascular disease, ischemic heart disease, vascular dementia, urinary incontinence, multiple sclerosis, and other diseases are more common among older adults. According to the World Health Organization (WHO), by 2030, one in six people in the world will be aged 60 years or over, and by 2050, the world’s population of people aged 60 years and older will double (2.1 billion). This in turn is expected to increase demand for medical implants.

Global Medical Implants Market Opportunities:

Rise in adoption or demand for medical implants across the globe is expected to provide significant growth opportunities for players in the medical implants market. For instance, with the increasing disease burden and increase in awareness among people, the demand for safe and effective medical implants is also increasing with the rapid pace. In February 2022, 4WEB Medical launched array of Hyperlordotic lateral spine implants, the Hyperlordotic Lateral Spine Truss System (LTST). A new addition to the LTST portfolio includes 18, 24, and 300 lordotic angles in anterior longitudinal release procedures for spine correction.

Increasing prevalence/incidence of musculoskeletal disorders (MSD) around the world is expected to offer significant growth opportunities for players in the medical implants market. For instance, musculoskeletal disorders are injuries or disorders of the muscles, nerves, tendons, joints, cartilage, and spinal discs. Therefore, with the rise in burden of musculoskeletal disorders, the demand for medical implants is also growing. In February 2022, DeGen Medical, Inc. announced the launch of Impulse AM, a 3D-printed porous titanium implant for posterior interbody fusion. Impulse AM comes in a variety of sizes and anatomical designs to accommodate a range of patient anatomy. 

Medical Implants Market Report Coverage

Report Coverage Details
Base Year: 2022 Market Size in 2023: US$ 109.9 Bn
Historical Data for: 2017 to 2021 Forecast Period: 2023 to 2030
Forecast Period 2023 to 2030 CAGR: 7.2% 2030 Value Projection: US$ 178.79 Bn
Geographies covered:
  • North America: U.S. and Canada
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Middle East and Africa: GCC Countries, Israel, Rest of Middle East, South Africa, North Africa, and Central Africa
Segments covered:
  • By Product: (((Orthopedic implants (Reconstructive Joint Replacements (Knee Replacement Implants, Hip Replacement Implants, and Extremities), Orthobiologics, and Trauma & Craniomaxillofacial), Cardiovascular Implants (Pacing Devices (Cardiac Resynchronization Therapy Devices (CRTs) (CRT-P (CRT with pacemaker function) and CRT-D (CRT with pacemaker and ICD function)), Implantable Cardioverter Defibrillators (ICDs) (Transvenous Implantable Cardioverter Defibrillator (T-ICDs) Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs), and Implantable Cardiac Pacemakers (ICPs)), Stents (Coronary stents (Drug-eluting Stents (DES), Bare-metal Coronary Stents, and Bioabsorbable Stents) and Peripheral stents (Iliac, Femoral-Popliteal, Renal, Carotid), Stent-related Implants (Synthetic Grafts and Vena Cava Filters), Structural Cardiac Implants (Mechanical Heart Valves, Implantable Ventricular-assist Devices (LVAD, RVAD, BIVAD), Spinal Implants (Spinal fusion implants, Spinal bone stimulators, Vertebral Compression Fracture (VCF) Devices, and Motion Preservation Devices/Non-Fusion Devices), and Neurostimulators (Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), Vagus Nerve Stimulation (VNS), Spinal Cord Stimulation (SCS), and Other neurostimulators), Opthalmic Implants (Intraocular Lens and Glaucoma Implants), Dental Implants (Plate Form Dental Implants and Root Form Dental Implants), Facial Implants, and Breast implants)))
  • By Biomaterial Type: Metallic Biomaterials, Ceramic Biomaterials, Polymers Biomaterials, and Natural Biomaterials
Companies covered:

Biotronik, Inc., Livanova Plc, NuVasive, Inc., and Institut Straumann AG, among others.

Growth Drivers: Increase in prevalence of chronic disease
Growing geriatric (aging) population 
Restraints & Challenges: High cost of treatment
Stringent rules/regulations or stringent approval process

Global Medical Implants Market Trends:

Rise in demand for orthopedic implants is a recent trend

Orthopedic implants are used to replace missing joints and/or bones or to support damaged bones. These implants have seen a shift from conventional surgical procedures to modern fixation and prosthetic devices, and the increased risk of osteoporosis, osteoarthritis, and other musculoskeletal disorders of the senior population has significantly increased the demand for orthopedic implants. This trend is expected to continue over the forecast period, driving the market growth.

Rise in awareness among people is another trend

The Medical Device Innovation Consortium (MDIC) is trying to increase the awareness for latest technology among patients and surgeons by conducting seminars and conferences where they can showcase their novel technologies and devices. Moreover, rise in awareness among people about these implants and associated benefits as well as established infrastructure is expected to increase demand for medical implants. This trend is also expected to continue during the forecast period, driving the growth of the global medical implants market.

Global Medical Implants Market Restraints:

High cost of treatment to hinder market growth

One of the key factors expected to hamper the growth of the global medical implants market is the high cost of treatment. High cost is associated with procedures involving medical implants such as heart valve replacement, joint reconstruction, dental implant, and breast implant. For instance, total knee replacement can cost around US$ 35,000 without insurance in the United States. Moreover, the cost for these surgeries increases if there are post-surgery complications and in cases where there is an increase in length of hospital stay. 

Stringent rules/regulations to hamper market growth

Another factor which is hampering growth of the global medical implants market is the stringent rules/regulations or stringent approval process. Most counties worldwide have a stringent approval process for medical implants, as they are highly specialized devices that are implanted in the body. For instance, the U.S. Food and Drug Administration (FDA) is accountable for safeguarding public health by supervision of medical products, including medical implants. Manufacturers are required to obtain either Pre-Market Approval (PMA) or 510K clearance from FDA (in the U.S.) in order to introduce their product to the market.

Figure 2. Global Medical Implants Market Share (%), by Product, 2023

MEDICAL IMPLANTS MARKET

To learn more about this report, request a free sample copy

Global Medical Implants Market Segmentation:

The global medical implants market report is segmented into Product, Biomaterial Type, and Region.

Based on Product, the market is segmented into Orthopedic Implants, Cardiovascular Implants, Opthalmic Implants, Dental Implants, Facial Implants, and Breast implants. Of which, Orthopedic Implants Segment is expected to dominate the medical implants market over the forecast period and this is attributed to the increasing prevalence/incidence of musculoskeletal disorders.

Cardiovascular Implants Segment is also expected to witness robust growth in the near future and this is owing to the rise in burden of cardiovascular diseases and increase in demand for cardiac implants across the globe.

Based on Biomaterial Type, the market is segmented into Metallic Biomaterials, Ceramic Biomaterials, Polymers Biomaterials, and Natural Biomaterials. Of which, Metallic Biomaterials Segment is expected to dominate the market over the forecast period and this is attributed to the rise in usage of metallic biomaterials in medical devices. Metallic biomaterials are used largely in joint replacements, dental implants, orthopedic fixations, and stents.

Ceramic Biomaterials Segment is also expected to witness significant growth in the near future and this is due to increase in demand for dental and bone implants. Ceramic biomaterials are used largely in medical procedures, such as dental and bone implants.

Global Medical Implants Market: Key Developments

In June 2022, ZimVie Inc. announced the launch of the Food and Drug Administration-cleared T3 PRO Tapered Implant and Encode Emergence Healing Abutment in the U.S. It is newest addition to ZimVie’s family of dental implants and builds on the proven solutions of T3 Tapered Implant.

In February 2022, DeGen Medical, Inc. announced the launch of Impulse AM, a 3D-printed porous titanium implant for posterior interbody fusion.

In March 2022, SurGenTec received clearance from the U.S. Food & Drug Administration (FDA) for ION Screw, its proprietary stand-alone spine fixation implant.

In June 2021, Colfax Corp.’s DJO announced that it entered into a definitive agreement to acquire Mathys AG Bettlach. The acquisition is expected to strengthen DJO’s patient-focused innovation pipeline and broaden its reconstructive portfolio.

Global Medical Implants Market: Key Companies Insights

The global medical implants market is highly competitive. This is attributed to the rise in burden of chronic disease and growing geriatric (aging) population, as a result, players in the market are focusing on launching novel products in the market.

Some of the key players in the global medical implants market are Biotronik, Inc., Livanova Plc, NuVasive, Inc., and Institut Straumann AG, among others.

*Definition: Medical implants are medical devices that are placed inside or on the surface of the body. These implants can be placed permanently or they can be removed once they are no longer needed. For instance, stents or hip implants are intended to be permanent. But chemotherapy ports or screws to repair broken bones can be removed when they no longer needed.  

Frequently Asked Questions

The global medical implants market size is estimated to be valued at US$ 109.9 Billion in 2023 and is expected to exhibit a CAGR of 7.2% between 2023 and 2030.

Rise in prevalence of chronic disease and growing geriatric population around the world is fueling the market.

The Orthopaedic Implants segment is the leading component segment in the market.

High cost of treatment, stringent rules/regulations, and stringent approval process are major factors restraining market.

Major players operating in the market are Biotronik, Inc., Livanova Plc, NuVasive, Inc., and Institut Straumann AG, among others.

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount
Logo

Reliability and Reputation

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Reliability and Reputation

27001:2022

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo